4.5 Review

Transcriptional Control by NF-κB: Elongation in Focus

Journal

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.bbagrm.2013.04.007

Keywords

NF-kappa B; transcription elongation; P-TEFb; Brd4; DSIF

Funding

  1. Israel Science Foundation [816/09]
  2. Israel Cancer Research Fund
  3. Israel Cancer Association

Ask authors/readers for more resources

The NF-kappa B family of transcription factors governs the cellular reaction to a variety of extracellular signals. Following stimulation, NF-kappa B activates genes involved in inflammation, cell survival, cell cycle, immune cell homeostasis and more. This review focuses on studies of the past decade that uncover the transcription elongation process as a key regulatory stage in the activation pathway of NF-kappa B. Of interest are studies that point to the elongation phase as central to the selectivity of target gene activation by NF-kappa B. Particularly, the cascade leading to phosphorylation and acetylation of the NF-kappa B subunit p65 on serine 276 and lysine 310, respectively, was shown to mediate the recruitment of Brd4 and P-TEFb to many pro-inflammatory target genes, which in turn facilitate elongation and mRNA processing. On the other hand, some anti-inflammatory genes are refractory to this pathway and are dependent on the elongation factor DSIF for efficient elongation and rnRNA processing. While these studies have advanced our knowledge of NF-kappa B transcriptional activity, they have also raised unresolved issues regarding the specific genomic and physiological contexts by which NF-kappa B utilizes different mechanisms for activation. (c) 2013 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available